Your browser is no longer supported. Please, upgrade your browser.
Settings
GNMK GenMark Diagnostics, Inc. daily Stock Chart
GNMK [NASD]
GenMark Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.91 Insider Own4.30% Shs Outstand58.76M Perf Week-5.92%
Market Cap391.93M Forward P/E- EPS next Y-0.56 Insider Trans-9.71% Shs Float53.32M Perf Month-6.06%
Income-51.20M PEG- EPS next Q-0.21 Inst Own92.80% Short Float3.62% Perf Quarter-8.76%
Sales71.60M P/S5.47 EPS this Y25.00% Inst Trans-2.22% Short Ratio6.21 Perf Half Y33.40%
Book/sh0.43 P/B15.51 EPS next Y30.90% ROA-54.10% Target Price10.14 Perf Year-3.61%
Cash/sh0.82 P/C8.10 EPS next 5Y- ROE-137.00% 52W Range3.58 - 8.81 Perf YTD37.24%
Dividend- P/FCF- EPS past 5Y1.00% ROI-68.90% 52W High-23.17% Beta1.49
Dividend %- Quick Ratio3.40 Sales past 5Y20.90% Gross Margin29.60% 52W Low89.11% ATR0.34
Employees477 Current Ratio3.90 Sales Q/Q4.40% Oper. Margin-66.90% RSI (14)38.79 Volatility4.45% 4.65%
OptionableYes Debt/Eq0.00 EPS Q/Q-3.20% Profit Margin-71.40% Rel Volume0.55 Prev Close6.67
ShortableYes LT Debt/Eq1.96 EarningsApr 30 AMC Payout- Avg Volume310.91K Price6.77
Recom- SMA20-7.76% SMA50-6.82% SMA2004.17% Volume14,806 Change1.50%
Feb-22-19Reiterated Needham Buy $12
Nov-03-17Reiterated Needham Buy $15 → $11
Nov-03-17Downgrade Raymond James Outperform → Mkt Perform
Sep-18-17Initiated BofA/Merrill Buy $13
Sep-13-17Reiterated Needham Buy $17 → $15
Aug-31-17Resumed BTIG Research Buy $13
Jun-13-17Reiterated Needham Buy $16 → $17
Jan-24-17Reiterated Needham Buy $13 → $15
Feb-24-16Reiterated Needham Buy $13 → $11
Oct-28-15Reiterated Needham Buy $16 → $13
May-06-15Reiterated Canaccord Genuity Buy $16 → $14
Apr-17-15Reiterated Canaccord Genuity Buy $17 → $16
Dec-19-13Initiated Needham Buy $17
Aug-08-13Reiterated Canaccord Genuity Buy $18 → $14
Apr-15-13Reiterated Canaccord Genuity Buy $14 → $18
Jan-15-13Reiterated Canaccord Genuity Buy $12 → $14
May-23-19 04:05PM  GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire
May-02-19 09:10AM  Edited Transcript of GNMK earnings conference call or presentation 30-Apr-19 8:30pm GMT Thomson Reuters StreetEvents
May-01-19 04:05PM  GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference GlobeNewswire +7.18%
Apr-30-19 10:12PM  GenMark Diagnostics Inc (GNMK) Q1 2019 Earnings Call Transcript Motley Fool
05:41PM  GenMark Diagnostics: 1Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports First Quarter 2019 Results GlobeNewswire
04:02PM  GenMark Diagnostics Expands Commercial Team GlobeNewswire
Apr-24-19 09:20AM  Is GenMark Diagnostics, Inc. (NASDAQ:GNMK) Potentially Undervalued? Simply Wall St.
Apr-23-19 10:32AM  GenMark Diagnostics (GNMK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks
Apr-15-19 07:45AM  GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019 GlobeNewswire
07:30AM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel GlobeNewswire
Apr-01-19 01:25PM  GenMark Diagnostics (NASDAQ:GNMK) Shareholders Booked A 38% Gain In The Last Year Simply Wall St.
Mar-08-19 08:14AM  Does The GenMark Diagnostics, Inc. (NASDAQ:GNMK) Share Price Tend To Follow The Market? Simply Wall St.
Mar-01-19 06:23AM  Edited Transcript of GNMK earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-25-19 10:48PM  GenMark Diagnostics Inc (GNMK) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Feb-21-19 08:54PM  GenMark Diagnostics Inc (GNMK) Q4 2018 Earnings Conference Call Transcript Motley Fool
05:25PM  GenMark Diagnostics (GNMK) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:38PM  GenMark Diagnostics: 4Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results GlobeNewswire
04:03PM  GenMark Diagnostics Announces Expansion of Executive Leadership Team GlobeNewswire
Feb-20-19 04:55PM  GenMark Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire +7.51%
Feb-14-19 10:31AM  Will GenMark Diagnostics (GNMK) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-13-19 02:20PM  How Much Are GenMark Diagnostics, Inc. (NASDAQ:GNMK) Insiders Taking Off The Table? Simply Wall St.
Feb-07-19 04:43PM  GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019 GlobeNewswire
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE -5.87%
Jan-30-19 07:25AM  New Research Coverage Highlights Cummins, R.R. Donnelley & Sons, James River Group, HNI, GenMark Diagnostics, and EP Energy Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-08-19 02:00PM  Should You Worry About GenMark Diagnostics, Inc.s (NASDAQ:GNMK) CEO Pay Cheque? Simply Wall St. +10.15%
08:00AM  GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018 GlobeNewswire
Dec-27-18 10:24AM  GenMark Bulls Emboldened By Accelerated ePlex Panel Clearance Benzinga +5.01%
Dec-26-18 08:00AM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel GlobeNewswire +14.62%
Dec-23-18 01:15AM  Is GenMark Diagnostics, Inc (GNMK) A Good Stock To Buy? Insider Monkey
Dec-20-18 02:15PM  GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel GlobeNewswire
Dec-19-18 05:22PM  GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference GlobeNewswire
Nov-29-18 10:39AM  How Financially Strong Is GenMark Diagnostics Inc (NASDAQ:GNMK)? Simply Wall St.
Nov-07-18 04:05PM  GenMark Diagnostics to Present at Upcoming Investor Conferences GlobeNewswire +9.73%
Nov-06-18 07:50AM  Analysis: Positioning to Benefit within Hess Midstream Partners LP, Quanta Services, ServiceSource International, Meritor, Donegal Group, and GenMark Diagnostics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -6.75%
Nov-01-18 11:06AM  Edited Transcript of GNMK earnings conference call or presentation 29-Oct-18 8:30pm GMT Thomson Reuters StreetEvents -5.25%
Oct-29-18 06:35PM  GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:29PM  GenMark Diagnostics: 3Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Third Quarter 2018 Results GlobeNewswire
Oct-15-18 04:05PM  GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018 GlobeNewswire
11:28AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Cash Is King Simply Wall St.
09:25AM  Analysis: Positioning to Benefit within PTC, H&R Block, GenMark Diagnostics, American International Group, Newmont Mining, and Stryker Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Oct-02-18 04:14PM  GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels GlobeNewswire
Sep-07-18 08:28AM  Is GenMark Diagnostics Inc (NASDAQ:GNMK) An Industry Laggard Or Leader? Simply Wall St.
Aug-23-18 05:45PM  Edited Transcript of GNMK earnings conference call or presentation 30-Jul-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-18 08:30AM  Recent Analysis Shows SUPERVALU INC, GenMark Diagnostics, E.W. Scripps, Cooper Tire & Rubber, Nexstar Broadcasting Group, and Cloud Peak Energy Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jul-30-18 06:35PM  GenMark Diagnostics (GNMK) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:29PM  GenMark Diagnostics: 2Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports Second Quarter 2018 Results GlobeNewswire
02:30PM  GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Jul-25-18 04:03PM  GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference GlobeNewswire
Jul-16-18 05:31PM  GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018 GlobeNewswire
Jun-28-18 04:57PM  GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel GlobeNewswire -5.26%
Jun-21-18 10:41AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Does The -15.12% Earnings Drop Reflect A Longer Term Trend? Simply Wall St.
Jun-06-18 08:00AM  GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference GlobeNewswire
May-25-18 07:13AM  GenMark Diagnostics Inc (NASDAQ:GNMK): Is Breakeven Near? Simply Wall St.
May-14-18 08:15AM  Analysis: Positioning to Benefit within Cirrus Logic, Aaron's, Waste Connections, Shake Shack, R.R. Donnelley & Sons, and GenMark Diagnostics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 04:03PM  GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference GlobeNewswire +7.21%
May-01-18 07:47PM  Edited Transcript of GNMK earnings conference call or presentation 1-May-18 8:30pm GMT Thomson Reuters StreetEvents
05:32PM  GenMark Diagnostics: 1Q Earnings Snapshot Associated Press
04:05PM  GenMark Diagnostics Reports First Quarter 2018 Results GlobeNewswire
Apr-17-18 04:03PM  GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018 GlobeNewswire
Apr-09-18 07:01PM  Cramer Remix: Ignoring Washington negatives could benefit... CNBC Videos
Mar-08-18 07:20AM  Blog Exposure - Zimmer Biomet Showcased New Product and Service Innovations at American Academy of Orthopaedic Surgeons Annual Meeting 2018 ACCESSWIRE
Mar-07-18 07:40AM  Free Post Earnings Research Report: Steris Revenues Grew 2%; Adjusted EPS Advanced 14% ACCESSWIRE
Feb-28-18 10:16AM  Edited Transcript of GNMK earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents -15.05%
Feb-27-18 07:11PM  GenMark Diagnostics reports 4Q loss Associated Press +7.06%
04:03PM  GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
12:40PM  GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-18 04:03PM  GenMark Diagnostics to Present at Upcoming Investor Conferences GlobeNewswire
Feb-13-18 04:03PM  GenMark Diagnostics Schedules Fourth Quarter and Full Year 2017 Financial Results Conference Call for February 27, 2018 GlobeNewswire
Feb-12-18 08:00AM  Research Report Identifies Waste Connections, Hercules Capital, Crown, GenMark Diagnostics, Clorox, and Cavium with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-19-18 01:08PM  8 Stocks That Will Hit All-Time Lows in 2018 InvestorPlace
Jan-09-18 07:05AM  GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2017 GlobeNewswire
Dec-21-17 04:03PM  GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference GlobeNewswire
Nov-21-17 11:52AM  ETFs with exposure to GenMark Diagnostics, Inc. : November 21, 2017 Capital Cube
08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Waste Connections, Hercules Capital, Scientific Games, GenMark Diagnostics, Clorox, and Cavium New Research Emphasizes Economic Growth GlobeNewswire
Nov-16-17 06:08PM  Lifshitz & Miller LLP Announces Investigation of CBBC Bancorp, Clifton Bancorp Inc., Dynegy, Inc., GenMark Diagnostics, Inc., Impax Laboratories, Inc., RPM International Inc. and XBiotech Inc. PR Newswire
Nov-14-17 03:07PM  GNMK INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of GenMark Diagnostics, Inc. Investors Business Wire
Nov-11-17 07:19PM  ACT NOW: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK PR Newswire
Nov-10-17 01:30PM  Glancy Prongay & Murray LLP Continues Investigation on Behalf of GenMark Diagnostics, Inc. Investors (GNMK) Business Wire
Nov-09-17 12:45PM  ETFs with exposure to GenMark Diagnostics, Inc. : November 9, 2017 Capital Cube
Nov-08-17 07:30AM  GNMK INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of GenMark Diagnostics, Inc. Investors Business Wire +20.24%
Nov-07-17 09:30PM  GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire +7.61%
02:26PM  Edited Transcript of GNMK earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GenMark Diagnostics, Inc. (GNMK) ACCESSWIRE
08:00AM  GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-03-17 05:29PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of GenMark Diagnostics, Inc. Investors (GNMK) Business Wire -41.32%
03:27PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GenMark Diagnostic, Inc. - GNMK PR Newswire
01:55PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GenMark Diagnostics, Inc. (GNMK) PR Newswire
12:39PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against GenMark Diagnostics, Inc. GNMK Business Wire
Nov-02-17 06:32PM  GenMark Diagnostics reports 3Q loss Associated Press
04:05PM  GenMark Diagnostics Reports Third Quarter 2017 Results Business Wire
11:00AM  GenMark Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-17 11:53AM  ETFs with exposure to GenMark Diagnostics, Inc. : October 30, 2017 Capital Cube
Oct-16-17 09:53AM  ETFs with exposure to GenMark Diagnostics, Inc. : October 16, 2017 Capital Cube
Oct-12-17 02:54PM  Is GenMark Diagnostics Inc (GNMK) Undervalued? Simply Wall St.
Oct-05-17 11:03AM  ETFs with exposure to GenMark Diagnostics, Inc. : October 5, 2017 Capital Cube
Oct-04-17 09:25AM  GenMark Diagnostics, Inc. :GNMK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017 Capital Cube
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. It provides ePlex instrument and respiratory pathogen panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results. The company offers XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It also provides diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, thrombophilia risk test, a warfarin sensitivity test, and hepatitis C virus genotyping test and associated custom manufactured reagents, as well as 2C19 genotyping test. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mendel ScottChief Operating OfficerMay 21Sale6.831,90713,025347,897May 22 05:08 PM
Ek John FrederickChief Financial OfficerMay 21Sale6.834953,381177,963May 22 05:07 PM
MASSARANY HANYPresident and CEOMay 21Sale6.837,83753,527841,567May 22 05:05 PM
Gleeson MichaelSVP, Corp. AccountsMay 21Sale6.831,76612,062361,335May 22 05:01 PM
Jensen TylerSVP, Engineering and Tech DevMay 21Sale6.833092,110135,349May 22 04:59 PM
Stier EricSVP & General CounselMay 21Sale6.831,65211,283240,102May 22 04:56 PM
Mitchell Brian AndrewSVP, OperationsMay 17Sale7.014483,140208,878May 20 04:52 PM
Gleeson MichaelSVP, Corp. AccountsMay 06Sale8.0010,00080,000363,101May 07 04:34 PM
Mitchell Brian AndrewSVP, OperationsMay 03Sale7.796545,095209,326May 06 04:40 PM
McNally James B.SVP, Sales and MarketingMay 03Sale7.799287,229263,517May 06 04:34 PM
Gleeson MichaelSVP, Corp. AccountsApr 15Sale7.5110,00075,100373,101Apr 16 04:26 PM
Gleeson MichaelSVP, Corp. AccountsFeb 28Sale7.8418,464144,758383,101Mar 01 05:58 PM
Gleeson MichaelSVP, Corp. AccountsFeb 27Sale7.9626,704212,564401,565Mar 01 05:58 PM
Stier EricSVP & General CounselFeb 25Sale6.8011,24376,452241,754Feb 27 04:38 PM
MASSARANY HANYPresident and CEOFeb 25Sale6.7954,596370,707849,404Feb 27 04:37 PM
Ek John FrederickChief Financial OfficerFeb 25Sale6.795,20535,342178,458Feb 27 04:33 PM
Mitchell Brian AndrewSVP, OperationsFeb 25Sale6.7910,99674,663209,980Feb 27 04:30 PM
Mendel ScottChief Operating OfficerFeb 25Sale6.8011,41077,588349,804Feb 27 04:27 PM
McNally James B.SVP, Sales and MarketingFeb 25Sale6.7912,29783,497264,445Feb 27 04:15 PM
Gleeson MichaelSVP, Corp. AccountsFeb 25Sale6.7912,09782,139428,269Feb 27 04:12 PM
Ek John FrederickChief Financial OfficerFeb 20Sale6.165953,665183,663Feb 21 09:25 PM
Stier EricSVP & General CounselFeb 20Sale6.161,98612,234252,997Feb 21 07:10 PM
Gleeson MichaelSVP, Corp. AccountsFeb 20Sale6.162,12113,065440,366Feb 21 07:08 PM
MASSARANY HANYPresident and CEOFeb 20Sale6.165,56234,262904,000Feb 21 07:07 PM
Mendel ScottChief Operating OfficerFeb 20Sale6.162,06312,708361,214Feb 21 07:14 PM
Mitchell Brian AndrewSVP, OperationsFeb 19Sale6.325193,280220,976Feb 21 07:11 PM
Stier EricSVP & General CounselJan 23Sale5.903,59621,216183,733Jan 25 06:33 PM
McNally James B.SVP, Sales and MarketingJan 23Sale5.904,73027,907175,492Jan 25 06:28 PM
MASSARANY HANYPresident and CEOJan 23Sale5.9015,16689,479692,062Jan 25 06:25 PM
Gleeson MichaelSVP, Corp. AccountsJan 23Sale5.903,97423,447367,487Jan 25 06:21 PM
Mitchell Brian AndrewSVP, OperationsJan 23Sale5.903,97423,447146,495Jan 25 06:18 PM
Mendel ScottChief Financial OfficerJan 23Sale5.905,29731,252235,777Jan 25 06:16 PM
MASSARANY HANYPresident and CEOJan 17Option Exercise0.0040,2290707,228Jan 22 07:37 PM
McNally James B.SVP, Sales and MarketingJan 17Option Exercise0.0011,4280180,222Jan 22 07:35 PM
Stier EricSVP & General CounselJan 17Option Exercise0.008,6850187,329Jan 22 07:33 PM
Mendel ScottChief Financial OfficerJan 17Option Exercise0.0012,8000241,074Jan 22 07:29 PM
Mitchell Brian AndrewSVP, OperationsJan 17Option Exercise0.009,6000150,469Jan 22 07:27 PM
Gleeson MichaelSVP, Corp. AccountsJan 17Option Exercise0.009,6000371,461Jan 22 07:24 PM
Gleeson MichaelSVP, Corp. AccountsNov 27Sale5.089704,928361,861Nov 29 04:36 PM
Stier EricSVP & General CounselNov 27Sale5.089304,724178,644Nov 29 04:34 PM
MASSARANY HANYPresident and CEONov 27Sale5.085,88429,891666,999Nov 29 04:32 PM
Mitchell Brian AndrewSVP, OperationsNov 27Sale5.082191,113140,869Nov 29 04:30 PM
Mendel ScottChief Financial OfficerNov 27Sale5.081,2926,563228,274Nov 29 04:27 PM
McNally James B.SVP, Sales and MarketingNov 27Sale5.082191,113168,794Nov 29 04:26 PM
Gleeson MichaelSVP, Corp. AccountsNov 20Sale4.841,8148,780362,831Nov 26 05:05 PM
Stier EricSVP & General CounselNov 20Sale4.841,6978,213179,574Nov 26 04:54 PM
MASSARANY HANYPresident and CEONov 20Sale4.848,04738,947672,883Nov 26 04:50 PM
Mendel ScottChief Financial OfficerNov 20Sale4.841,9599,482229,566Nov 26 04:46 PM
Mitchell Brian AndrewSVP, OperationsNov 19Sale4.994182,086141,088Nov 20 03:52 PM
MASSARANY HANYPresident and CEONov 05Sale4.851,5617,571680,930Nov 06 04:53 PM
Stier EricSVP & General CounselNov 05Sale4.853501,698181,271Nov 06 04:52 PM
Gleeson MichaelSVP, Corp. AccountsNov 05Sale4.853821,853364,645Nov 06 04:48 PM
Mitchell Brian AndrewSVP, OperationsNov 05Sale4.856833,313141,506Nov 06 04:46 PM
Mendel ScottChief Financial OfficerNov 05Sale4.852261,096231,525Nov 06 04:44 PM
McNally James B.SVP, Sales and MarketingNov 05Sale4.851,6447,973169,013Nov 06 04:42 PM
Gleeson MichaelSVP, North American Com. Ops.Aug 24Sale7.161,0227,318365,027Aug 27 01:15 PM
Williams Jennifer AnneSVP, Human ResourcesAug 24Sale7.161,0647,618193,366Aug 27 01:12 PM
MASSARANY HANYPresident and CEOAug 24Sale7.166,20344,413682,491Aug 27 01:10 PM
Stier EricSVP & General CounselAug 24Sale7.169797,010181,621Aug 27 01:07 PM
Mendel ScottChief Financial OfficerAug 24Sale7.161,3619,745231,751Aug 27 01:02 PM
McNally James B.SVP, Marketing & Bus DevAug 24Sale7.162301,647150,657Aug 27 01:22 PM
Mitchell Brian AndrewSVP, OperationsAug 24Sale7.162301,647142,189Aug 27 01:20 PM
Mendel ScottChief Financial OfficerAug 21Sale7.391,91514,152233,112Aug 22 05:52 PM
Williams Jennifer AnneSVP, Human ResourcesAug 21Sale7.391,80913,369194,430Aug 22 05:48 PM
Stier EricSVP & General CounselAug 21Sale7.391,65912,260182,600Aug 22 05:44 PM
Gleeson MichaelSVP, North American Com. Ops.Aug 21Sale7.391,77413,110366,049Aug 22 05:41 PM
MASSARANY HANYPresident and CEOAug 21Sale7.396,01044,414688,694Aug 22 05:37 PM
Mitchell Brian AndrewSVP, OperationsAug 17Sale7.404263,152142,419Aug 20 05:36 PM
Williams Jennifer AnneSVP, Human ResourcesAug 03Sale7.202932,110196,239Aug 06 07:43 PM
Stier EricSVP & General CounselAug 03Sale7.203222,318184,259Aug 06 07:32 PM
Gleeson MichaelSVP, North American Com. Ops.Aug 03Sale7.203512,527367,823Aug 06 07:28 PM
MASSARANY HANYPresident and CEOAug 03Sale7.201,0047,229694,704Aug 06 07:25 PM
Mendel ScottChief Financial OfficerAug 03Sale7.202071,490235,027Aug 07 01:36 PM
McNally James B.SVP, Marketing & Bus DevAug 03Sale7.206804,896150,887Aug 07 01:34 PM
Mitchell Brian AndrewSVP, OperationsAug 03Sale7.206284,522142,845Aug 07 01:31 PM